The expanding demand for precise immunological study and therapeutic development has spurred significant progress in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently generated using various expression systems, including bacterial hosts, higher cell lines, and viral replicat